EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Complement C5a Promotes Epithelial-Mesenchymal Transition in Pterygium via C5aR Activation

Jiaxin Han, Qianwen Gong, He Wang, Bintao Xie, Lingying Ye, Lijun Shen, Liang Hu

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.6.16 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Jiaxin Han and 6 co-authors. Institution: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, People's Republic of China. Major MEDLINE topics: Pterygium, Epithelial-Mesenchymal Transition, Receptor, Anaphylatoxin C5a, Complement C5a. Cited 1 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

The purpose of this study was to investigate candidate regulatory proteins associated with the pathogenesis of pterygium and to explore their potential biological roles.

Methods

Paired pterygium and conjunctival tissues from the discovery cohort (n = 10) and the validation cohort (n = 3) were subjected to proteomic analysis (label-free/4D label-free) to identify candidate differentially expressed proteins (DEPs). Exploratory clinical correlation and diagnostic analyses of DEPs were performed. Functional validation was conducted using primary conjunctival epithelial cells (PCECs) treated with C5a with or without the C5aR antagonist PMX53. Assays included evaluation of epithelial-mesenchymal transition (EMT) markers (RT-qPCR, Western blot, and immunofluorescence), migration (wound-healing assay), apoptosis (flow cytometry), and VEGFA expression.

Results

Proteomic analysis showed that C5 was consistently upregulated, and upregulated DEPs were significantly enriched in the complement and coagulation cascades. Furthermore, C5 showed a significant positive correlation with vessel density (r = 0.68, P = 0.029) and achieved an area under the curve (AUC) of 0.8 in the discovery cohort. Functional validation demonstrated that C5a promoted EMT-like marker changes in PCECs, including decreased E-cadherin and increased vimentin and fibronectin (FN). C5a treatment was also associated with enhanced cellular migration and reduced apoptosis, and these cellular changes were attenuated by the C5aR antagonist PMX53. Notably, C5a also increased VEGFA expression.

Conclusions

These findings suggest that C5a/C5aR signaling may contribute to pterygium pathogenesis by promoting EMT-related changes in conjunctival epithelial cells, supporting C5aR as a potential therapeutic target.

Subjects

MeSH terms (MEDLINE)

PterygiumEpithelial-Mesenchymal TransitionReceptor, Anaphylatoxin C5aComplement C5aGene Expression RegulationHumansBlotting, WesternFemaleConjunctivaCells, CulturedCell MovementFlow CytometryEpithelial CellsApoptosisProteomicsMaleMiddle AgedVascular Endothelial Growth Factor AReal-Time Polymerase Chain Reaction

Substances

Receptor, Anaphylatoxin C5aComplement C5aC5AR1 protein, humanVascular Endothelial Growth Factor A

Authors and institutions

  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, People's Republic of China.
  • State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, People's Republic of China.
  • Department of Ophthalmology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, People's Republic of China.
  • Department of Ophthalmology, Zhejiang Provincial People's Hospital, Zhejiang, People's Republic of China.

Cite

APA

Han, J., Gong, Q., Wang, H., Xie, B., Ye, L., Shen, L., & Hu, L. (2026). Complement C5a Promotes Epithelial-Mesenchymal Transition in Pterygium via C5aR Activation. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.6.16

Vancouver

Han J, Gong Q, Wang H, Xie B, Ye L, Shen L, et al. Complement C5a Promotes Epithelial-Mesenchymal Transition in Pterygium via C5aR Activation. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.6.16

BibTeX
@article{Han2026,
  author = {Han, Jiaxin and Gong, Qianwen and Wang, He and Xie, Bintao and Ye, Lingying and Shen, Lijun and Hu, Liang},
  title = {Complement C5a Promotes Epithelial-Mesenchymal Transition in Pterygium via C5aR Activation},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.6.16}
}
Start for free →